Navigation Links
GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
Date:10/24/2008

known important human therapeutic proteins. GenOdyssee's technology is protected by the international patent application PCT/EP03/13965 and is the sole property of the company.

This technology has allowed GenOdyssee to identify in the population a variety of innovative variations on existing key protein drugs such as IFN alphas and EPO and to convert such variations into novel drug candidates. The company's lead virology and immunotherapy drug candidates are GEA007.1 and GEA009.2, respectively targeted at treatments of HCV infection and cancer.

For more information about the company, please visit the company's website at http://www.genodyssee.com

About GEA007.1

GEA007.1 is a novel and first in man natural human IFN alpha protein variant identified using the company's proprietary natural evolution technology. It is found in all major human populations (Pacific, Iberian, Italian, Mexican, African, Caucasian, Chinese, Indo-Pakistan, Middle-Eastern, Japanese). GEA007.1 is a naturally occurring variant of human IFN alpha 17, which incorporates an innovative amino acid substitution G45R that provides a novel positive charge together with a change in 3-D structure of the protein receptor binding site. The biochemical and structural modifications induced in the protein binding site provide for superior anti-HCV efficacy without increased toxicity of GEA007.1 as compared to IFN alpha 2 which is the core agent of current standard of care. Long lasting second generation pegylated IFN alpha 2's have given major improvements in HCV therapy in combination with ribavirin.

GEA007.1 is particularly positioned for use in HCV genotype 1 which has become the predominant genotype worldwide and which is the most difficult to treat, as well as in patients infected with HCV genotype 3 because of the following properties:

- Stronger anti-HCV activity in fresh human hepatocytes

infect
'/>"/>

SOURCE GenOdyssee SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2. Alfacell Receives Going Concern Audit Opinion
3. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
4. NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device
5. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
6. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
7. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
8. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 Reports from ... the United States suffer from one or more chronic ... or cancer. Medication can address some of these diseases, ... activities that many sufferers face. While implanted nerve stimulation ... stimulate the whole nerve, which can induce side effects. ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 With only ... time special on Sartorius Biohit products . The ... mLINE pipettes, Picus Electronic Pipette Trade-in Program, and free ... and Safety officers around the world. They are ideal ... Other features include:, ,     Full volume range ...
(Date:12/19/2014)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced the results of its annual general meeting ... transformational year in Relmada,s history and it set the ... Sergio Traversa , chief executive officer of Relmada. ... financial, human resource and clinical development objectives that position ...
(Date:12/17/2014)... Achim Noack has been named global vice president ... position, Noack will assist Jerry Stoller, CEO and president ... and supervise global marketing management and implementation of new ... and experience in the crop protection industry,” says Jerry ... thinking will be a great asset for Stoller Group, ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... 6 Sigma-Aldrich Corporation,(Nasdaq: SIAL ) will be ... Tuesday, May 13th at 10:40 AM Pacific Time in ... broadcast over the,Internet available at http://ir.sigmaaldrich.com . Users ... the webcast on, http://ir.sigmaaldrich.com users will need to ...
... 2.0 expert, to deliver keynote address at launch ... ... 6 Simon Revell, Manager of Enterprise,2.0 Technology Development at ... software can be leveraged to stimulate the advancement of science,and ...
... m2 (8600 Square-Foot) Facility Enabling Further ... Growth and Recruiting of New Staff, ... new 800 m2,(8600 square-foot) facility enabling further growth and recruiting ... the number of employees,by recruiting additional Protein Tomography(TM) analysts, sales,representatives ...
Cached Biology Technology:Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 2Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 3Sidec AB Expands Into New Offices 2
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... the blood cancer multiple myeloma has revealed that the genetic ... thought. Through results published in Cancer Cell today, ... patient,s tumor can harbor populations of cancer cells equipped with ... in the future. "What this new work shows us ...
... found a way to project future habitat locations ... threatened biodiversity. Associate Professor Grant Wardell-Johnson and ... for Biodiversity and Climate, along with lead researcher ... at Wageningen University in the Netherlands, developed an ...
... sensations, advanced ship design and more, four scientists sponsored ... 23 learned they will receive the nation,s highest honor ... been selected for Presidential Early Career Awards for Scientists ... ceremony at the White House early this year. ...
Cached Biology News:Multiple myeloma study uncovers genetic diversity within tumors 2Multiple myeloma study uncovers genetic diversity within tumors 3Safe havens revealed for biodiversity in a changed climate 2White House lauds ONR-funded researchers for early success 2